 Ombrabulin

Ombrabulin was an experimental drug candidate discovered by Ajinomoto and further developed by Sanofi-Aventis.Ombrabulin is a combretastatin A-4 derivative that exerts its antitumor effect by disrupting the formation of blood vessels needed for tumor growth.